SRX 0.00% 17.5¢ sierra rutile holdings limited

My thought are. No trifecta but a very good Double. 1/Response...

  1. 189 Posts.
    My thought are.
    No trifecta but a very good Double.
    1/Response rate was Higher with sirt by 7.4%
    2/Both the side effect profile and QUALITY OF LIFE was much better over time in the sirt group.
    3/ if patient Re not tolerant or have contraindications for Sorafenib therapy there are currently no standard of care .

    Paragraph 2 an 3 is the key for me.

    Yes i get it the primary end point did not show an overall survival superiority

    I the end quality of life is far more important.

    Glta
 
watchlist Created with Sketch. Add SRX (ASX) to my watchlist
(20min delay)
Last
17.5¢
Change
0.000(0.00%)
Mkt cap ! $74.27M
Open High Low Value Volume
17.5¢ 17.8¢ 17.5¢ $181.6K 1.032M

Buyers (Bids)

No. Vol. Price($)
5 4043406 17.5¢
 

Sellers (Offers)

Price($) Vol. No.
18.0¢ 2372524 39
View Market Depth
Last trade - 16.10pm 21/08/2024 (20 minute delay) ?
SRX (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.